Effects of ketamine-induced psychopathological symptoms on continuous overt rhyme fluency

被引:0
|
作者
Arne Nagels
André Kirner-Veselinovic
Richard Wiese
Frieder M. Paulus
Tilo Kircher
Sören Krach
机构
[1] Philipps-University Marburg,Department of Psychiatry and Psychotherapy
[2] RWTH Aachen University,Department of Psychiatry and Psychotherapy
[3] Philipps-University Marburg,Institute for German Linguistics
[4] Philipps-University Marburg,Department of Neurology
关键词
-methyl-; -aspartate receptor; Ketamine; fMRI; Speech production; Schizophrenia; Glutamate;
D O I
暂无
中图分类号
学科分类号
摘要
The N-methyl-d-aspartate receptor (NMDAR) has been implicated in the pathophysiology of schizophrenia. Administered to healthy individuals, a subanesthetic dose of the noncompetitive NMDAR antagonist ketamine reproduces several psychopathological symptoms commonly observed in patients with schizophrenia. In a counterbalanced, placebo-controlled, double-blind, within-participants study, fifteen healthy subjects were administered a continuous subanesthetic S-ketamine infusion while cortical activation was measured using functional magnetic resonance imaging. While being scanned, subjects performed an overt word generation task. Ketamine-induced psychopathological symptoms were assessed with the Positive and Negative Syndrome Scale (PANSS). Ketamine administration elicited effects on psychopathology, including difficulties in abstract thinking, lack of spontaneity and flow of conversation as well as formal thought disorder. On a behavioral level, verbal fluency performance was unaffected. The PANSS score for formal thought disorder positively correlated with activation measures encompassing the left superior temporal gyrus, the right middle and inferior frontal gyrus and the precuneus. Difficulty in abstract thinking was correlated with pronounced activations in prefrontal as well as in anterior cingulate regions, whereas hyperactivations in the left superior temporal gyrus were found in association with a lack of spontaneity and flow of conversation. In the absence of behavioral impairments during verbal fluency, NMDAR blocking evoked psychopathological symptoms and cortical activations in regions previously reported in schizophrenia patients. The results provide further support for the hypothesis of an NMDAR dysfunction in the pathophysiology of schizophrenia.
引用
收藏
页码:403 / 414
页数:11
相关论文
共 50 条
  • [41] Protective Effects of Trolox on Ketamine-Induced Memory Impairments and Morphological Changes in the Brain
    Uyar, Emre
    Erdinc, Meral
    Kelle, Ilker
    Erdinc, Levent
    Seker, Ugur
    Nergiz, Yusuf
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2025, 21 (01)
  • [42] The immune regulatory mechanism of ketamine-induced psychiatric disorders: A new perspective on drug-induced psychiatric symptoms
    Wang, Peipei
    Hu, Junmei
    Chen, Congliang
    Jiang, Zihan
    Zhang, Yu
    Lin, Kexin
    Liao, Linchuan
    Wang, Xia
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2025, 136
  • [43] Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology
    J M Stone
    C Dietrich
    R Edden
    M A Mehta
    S De Simoni
    L J Reed
    J H Krystal
    D Nutt
    G J Barker
    Molecular Psychiatry, 2012, 17 : 664 - 665
  • [44] S-(+)-ketamine-induced dissociative symptoms as a traumatic experience in patients with treatment-resistant depression
    Correia-Melo, Fernanda S.
    Silva, Samantha S.
    Araujo-de-Freitas, Lucas
    Quarantini, Lucas C.
    REVISTA BRASILEIRA DE PSIQUIATRIA, 2017, 39 (02) : 188 - 189
  • [45] Ketamine-induced lower urinary tract symptoms: a study of International Prostate Symptom Score and Quality of Life
    Wei, Y. B.
    Yang, J. R.
    Wu, W. W.
    Chinaegbomkpam, I. V.
    Jiang, G. Q.
    HONG KONG JOURNAL OF EMERGENCY MEDICINE, 2016, 23 (04) : 227 - 233
  • [46] Nicotine Fails to Attenuate Ketamine-Induced Cognitive Deficits and Negative and Positive Symptoms in Humans: Implications for Schizophrenia
    D'Souza, Deepak Cyril
    Ahn, Kyungheup
    Bhakta, Savita
    Elander, Jacqueline
    Singh, Nagendra
    Nadim, Haleh
    Jatlow, Peter
    Suckow, Raymond F.
    Pittman, Brian
    Ranganathan, Mohini
    BIOLOGICAL PSYCHIATRY, 2012, 72 (09) : 785 - 794
  • [47] A Potential Mechanism Underlying the Therapeutic Effects of Progesterone and Allopregnanolone on Ketamine-Induced Cognitive Deficits
    Cao, Ting
    Tang, MiMi
    Jiang, Pei
    Zhang, BiKui
    Wu, XiangXin
    Chen, Qian
    Zeng, CuiRong
    Li, NaNa
    Zhang, ShuangYang
    Cai, HuaLin
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [48] Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism
    Duncan, GE
    Miyamoto, S
    Leipzig, JN
    Lieberman, JA
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 293 (01): : 8 - 14
  • [49] Comparative effects of sertraline, haloperidol or olanzapine treatments on ketamine-induced changes in mouse behaviours
    O. J. Onaolapo
    T. B. Paul
    A. Y. Onaolapo
    Metabolic Brain Disease, 2017, 32 : 1475 - 1489
  • [50] Protective effects of 7-nitroindazole on ketamine-induced neurotoxicity in rat forebrain culture
    Wang, Cheng
    Sadovova, Natalya
    Patterson, Tucker A.
    Zou, Xiaoju
    Fu, Xin
    Hanig, Joseph P.
    Paule, Merle G.
    Ali, Syed F.
    Zhang, Xuan
    Slikker, William, Jr.
    NEUROTOXICOLOGY, 2008, 29 (04) : 613 - 620